HEADER TRANSCRIPTION REGULATION 18-JUN-03 1PQ9 TITLE HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: OXYSTEROLS RECEPTOR LXR-BETA; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 213-461; COMPND 5 SYNONYM: LIVER X RECEPTOR BETA, NUCLEAR ORPHAN RECEPTOR LXR-BETA, COMPND 6 UBIQUITOUSLY-EXPRESSED NUCLEAR RECEPTOR, NUCLEAR RECEPTOR NER; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H2 OR LXRB OR UNR OR NER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 STAR (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET 28A KEYWDS LXRB+T0901317 SPLIT, TRANSCRIPTION REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR M.FARNEGARDH,T.BONN,S.SUN,J.LJUNGGREN,H.AHOLA,A.WILHELMSSON,J.- AUTHOR 2 A.GUSTAFSSON,M.CARLQUIST REVDAT 6 03-APR-24 1PQ9 1 REMARK REVDAT 5 14-FEB-24 1PQ9 1 REMARK SEQADV REVDAT 4 13-JUL-11 1PQ9 1 VERSN REVDAT 3 24-FEB-09 1PQ9 1 VERSN REVDAT 2 25-NOV-03 1PQ9 1 JRNL REVDAT 1 09-SEP-03 1PQ9 0 JRNL AUTH M.FARNEGARDH,T.BONN,S.SUN,J.LJUNGGREN,H.AHOLA,A.WILHELMSSON, JRNL AUTH 2 J.-A.GUSTAFSSON,M.CARLQUIST JRNL TITL THE THREE-DIMENSIONAL STRUCTURE OF THE LIVER X RECEPTOR BETA JRNL TITL 2 REVEALS A FLEXIBLE LIGAND-BINDING POCKET THAT CAN JRNL TITL 3 ACCOMMODATE FUNDAMENTALLY DIFFERENT LIGANDS. JRNL REF J.BIOL.CHEM. V. 278 38821 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12819202 JRNL DOI 10.1074/JBC.M304842200 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.19 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 60499 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3201 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4432 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2530 REMARK 3 BIN FREE R VALUE SET COUNT : 231 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7474 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 181 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.40000 REMARK 3 B22 (A**2) : 0.32000 REMARK 3 B33 (A**2) : -1.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.236 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.195 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.400 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7738 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 7179 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10478 ; 1.376 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16637 ; 0.841 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 908 ; 5.126 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1184 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8385 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1616 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1732 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 7946 ; 0.226 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 4602 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 204 ; 0.180 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.177 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 73 ; 0.280 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.200 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4613 ; 0.750 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7457 ; 1.418 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3125 ; 2.093 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3021 ; 3.470 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1PQ9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUN-03. REMARK 100 THE DEPOSITION ID IS D_1000019494. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9393 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) REMARK 200 OPTICS : TOROIDAL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63700 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 55.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.27600 REMARK 200 FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.06600 REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: THYROID HORMONE RECEPTOR BETA LIGAND BINDING REMARK 200 DOMAIN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ISOPROPANOL, PEG 4000, HEPES, REMARK 280 GLYCEROL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.43300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.18900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.80300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.18900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.43300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.80300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 42940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -58.86600 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -103.60600 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -58.86600 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -103.60600 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 209 REMARK 465 SER A 210 REMARK 465 HIS A 211 REMARK 465 MET A 212 REMARK 465 GLY A 213 REMARK 465 GLU A 214 REMARK 465 GLY A 215 REMARK 465 GLU A 216 REMARK 465 GLY A 217 REMARK 465 VAL A 218 REMARK 465 GLN A 219 REMARK 465 LEU A 254 REMARK 465 GLY A 255 REMARK 465 ALA A 256 REMARK 465 ASP A 257 REMARK 465 PRO A 258 REMARK 465 GLN A 259 REMARK 465 SER A 260 REMARK 465 VAL A 459 REMARK 465 HIS A 460 REMARK 465 GLU A 461 REMARK 465 GLY B 209 REMARK 465 SER B 210 REMARK 465 HIS B 211 REMARK 465 MET B 212 REMARK 465 GLY B 213 REMARK 465 GLU B 214 REMARK 465 GLY B 215 REMARK 465 GLU B 216 REMARK 465 GLY B 217 REMARK 465 VAL B 218 REMARK 465 GLN B 259 REMARK 465 SER B 260 REMARK 465 VAL B 459 REMARK 465 HIS B 460 REMARK 465 GLU B 461 REMARK 465 GLY C 209 REMARK 465 SER C 210 REMARK 465 HIS C 211 REMARK 465 MET C 212 REMARK 465 GLY C 213 REMARK 465 GLU C 214 REMARK 465 GLY C 215 REMARK 465 GLU C 216 REMARK 465 GLY C 217 REMARK 465 VAL C 218 REMARK 465 GLN C 219 REMARK 465 SER C 244 REMARK 465 ASP C 245 REMARK 465 GLN C 246 REMARK 465 PRO C 247 REMARK 465 GLY C 255 REMARK 465 ALA C 256 REMARK 465 ASP C 257 REMARK 465 PRO C 258 REMARK 465 VAL C 459 REMARK 465 HIS C 460 REMARK 465 GLU C 461 REMARK 465 GLY D 209 REMARK 465 SER D 210 REMARK 465 HIS D 211 REMARK 465 MET D 212 REMARK 465 GLY D 213 REMARK 465 GLU D 214 REMARK 465 GLY D 215 REMARK 465 GLU D 216 REMARK 465 GLY D 217 REMARK 465 VAL D 218 REMARK 465 GLN D 219 REMARK 465 PHE D 243 REMARK 465 SER D 244 REMARK 465 ASP D 245 REMARK 465 GLN D 246 REMARK 465 PRO D 247 REMARK 465 LYS D 248 REMARK 465 PRO D 253 REMARK 465 LEU D 254 REMARK 465 GLY D 255 REMARK 465 ALA D 256 REMARK 465 ASP D 257 REMARK 465 PRO D 258 REMARK 465 GLN D 259 REMARK 465 LEU D 330 REMARK 465 LYS D 331 REMARK 465 ASP D 332 REMARK 465 LEU D 444 REMARK 465 GLN D 445 REMARK 465 ASP D 446 REMARK 465 LYS D 447 REMARK 465 VAL D 459 REMARK 465 HIS D 460 REMARK 465 GLU D 461 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 261 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 219 CG CD OE1 NE2 REMARK 470 ARG B 261 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 330 CG CD1 CD2 REMARK 470 LEU C 254 CG CD1 CD2 REMARK 470 LEU C 330 CG CD1 CD2 REMARK 470 SER D 260 OG REMARK 470 ARG D 261 CG CD NE CZ NH1 NH2 REMARK 470 PHE D 329 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER D 242 OE2 GLU D 281 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 284 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP B 338 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 MET C 227 CG - SD - CE ANGL. DEV. = -13.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 243 36.84 -140.27 REMARK 500 GLN A 445 32.61 -98.39 REMARK 500 ASP A 446 41.03 38.31 REMARK 500 ASP B 257 -161.94 -62.85 REMARK 500 LYS B 331 -68.35 89.57 REMARK 500 PHE B 379 50.55 -90.63 REMARK 500 THR C 250 124.17 -39.93 REMARK 500 PRO C 253 85.66 -65.43 REMARK 500 ARG C 408 -9.83 -58.61 REMARK 500 ARG D 241 -35.80 -36.09 REMARK 500 THR D 328 72.76 -115.66 REMARK 500 GLU D 388 68.75 -118.34 REMARK 500 ARG D 411 69.49 -116.07 REMARK 500 PRO D 451 -34.15 -38.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BNS A 1500 REMARK 610 BNS B 2500 REMARK 610 BNS C 3500 REMARK 610 BNS D 4500 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BNS A 1500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 44B A 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BNS B 2500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 44B B 2501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BNS C 3500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 44B C 3501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BNS D 4500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 44B D 4501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PQ6 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GW3965 REMARK 900 RELATED ID: 1PQC RELATED DB: PDB DBREF 1PQ9 A 213 461 UNP P55055 NR1H2_HUMAN 213 461 DBREF 1PQ9 B 213 461 UNP P55055 NR1H2_HUMAN 213 461 DBREF 1PQ9 C 213 461 UNP P55055 NR1H2_HUMAN 213 461 DBREF 1PQ9 D 213 461 UNP P55055 NR1H2_HUMAN 213 461 SEQADV 1PQ9 GLY A 209 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 SER A 210 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 HIS A 211 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 MET A 212 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 GLY B 209 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 SER B 210 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 HIS B 211 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 MET B 212 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 GLY C 209 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 SER C 210 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 HIS C 211 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 MET C 212 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 GLY D 209 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 SER D 210 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 HIS D 211 UNP P55055 CLONING ARTIFACT SEQADV 1PQ9 MET D 212 UNP P55055 CLONING ARTIFACT SEQRES 1 A 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 A 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 A 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 A 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 A 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 A 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 A 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 A 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 A 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 A 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 A 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 A 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 A 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 A 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 A 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 A 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 A 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 A 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 A 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 A 253 ILE TRP ASP VAL HIS GLU SEQRES 1 B 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 B 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 B 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 B 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 B 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 B 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 B 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 B 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 B 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 B 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 B 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 B 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 B 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 B 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 B 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 B 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 B 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 B 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 B 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 B 253 ILE TRP ASP VAL HIS GLU SEQRES 1 C 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 C 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 C 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 C 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 C 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 C 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 C 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 C 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 C 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 C 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 C 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 C 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 C 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 C 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 C 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 C 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 C 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 C 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 C 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 C 253 ILE TRP ASP VAL HIS GLU SEQRES 1 D 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 D 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 D 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 D 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 D 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 D 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 D 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 D 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 D 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 D 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 D 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 D 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 D 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 D 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 D 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 D 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 D 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 D 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 D 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 D 253 ILE TRP ASP VAL HIS GLU HET BNS A1500 9 HET 44B A1501 22 HET BNS B2500 9 HET 44B B2501 22 HET BNS C3500 9 HET 44B C3501 22 HET BNS D4500 9 HET 44B D4501 22 HETNAM BNS BENZENESULFONIC ACID HETNAM 44B 1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL) HETNAM 2 44B AMINO]PHENYL}PROPAN-2-OL FORMUL 5 BNS 4(C6 H6 O3 S) FORMUL 6 44B 4(C11 H8 F9 N O) FORMUL 13 HOH *181(H2 O) HELIX 1 1 THR A 221 SER A 244 1 24 HELIX 2 2 ARG A 261 GLN A 288 1 28 HELIX 3 3 GLY A 296 ARG A 319 1 24 HELIX 4 4 SER A 336 ALA A 343 1 8 HELIX 5 5 GLN A 346 GLY A 364 1 19 HELIX 6 6 ASP A 366 PHE A 379 1 14 HELIX 7 7 GLU A 388 ARG A 411 1 24 HELIX 8 8 LEU A 416 LEU A 444 1 29 HELIX 9 9 PRO A 450 ASP A 458 1 9 HELIX 10 10 THR B 221 ASN B 239 1 19 HELIX 11 11 ASN B 239 ASP B 245 1 7 HELIX 12 12 ARG B 261 VAL B 289 1 29 HELIX 13 13 GLY B 291 LEU B 295 5 5 HELIX 14 14 GLY B 296 ARG B 319 1 24 HELIX 15 15 LYS B 337 ALA B 343 1 7 HELIX 16 16 GLN B 346 GLY B 364 1 19 HELIX 17 17 ASP B 366 PHE B 379 1 14 HELIX 18 18 GLU B 388 ARG B 411 1 24 HELIX 19 19 LEU B 416 LEU B 444 1 29 HELIX 20 20 PRO B 450 ASP B 458 1 9 HELIX 21 21 THR C 221 ASN C 239 1 19 HELIX 22 22 SER C 260 GLN C 288 1 29 HELIX 23 23 GLY C 291 LEU C 295 5 5 HELIX 24 24 GLY C 296 ARG C 319 1 24 HELIX 25 25 SER C 336 ALA C 343 1 8 HELIX 26 26 GLN C 346 GLY C 364 1 19 HELIX 27 27 ASP C 366 PHE C 379 1 14 HELIX 28 28 GLU C 388 ARG C 411 1 24 HELIX 29 29 LEU C 416 GLN C 445 1 30 HELIX 30 30 PRO C 450 ASP C 458 1 9 HELIX 31 31 THR D 221 SER D 242 1 22 HELIX 32 32 SER D 260 VAL D 289 1 30 HELIX 33 33 GLY D 291 LEU D 295 5 5 HELIX 34 34 GLY D 296 ARG D 319 1 24 HELIX 35 35 SER D 336 ALA D 343 1 8 HELIX 36 36 GLN D 346 GLY D 364 1 19 HELIX 37 37 ASP D 366 PHE D 379 1 14 HELIX 38 38 GLU D 388 ARG D 411 1 24 HELIX 39 39 LEU D 416 ARG D 443 1 28 HELIX 40 40 PRO D 450 ASP D 458 1 9 SHEET 1 A 3 TYR A 320 ASN A 321 0 SHEET 2 A 3 CYS A 326 LEU A 330 -1 O CYS A 326 N ASN A 321 SHEET 3 A 3 PHE A 333 TYR A 335 -1 O PHE A 333 N LEU A 330 SHEET 1 B 3 TYR B 320 ASN B 321 0 SHEET 2 B 3 CYS B 326 PHE B 329 -1 O CYS B 326 N ASN B 321 SHEET 3 B 3 PHE B 333 SER B 336 -1 O TYR B 335 N ILE B 327 SHEET 1 C 3 TYR C 320 ASN C 321 0 SHEET 2 C 3 CYS C 326 LEU C 330 -1 O CYS C 326 N ASN C 321 SHEET 3 C 3 PHE C 333 TYR C 335 -1 O TYR C 335 N ILE C 327 SHEET 1 D 2 TYR D 320 ASN D 321 0 SHEET 2 D 2 CYS D 326 ILE D 327 -1 O CYS D 326 N ASN D 321 SITE 1 AC1 5 PHE A 271 SER A 278 THR A 316 PHE A 329 SITE 2 AC1 5 44B A1501 SITE 1 AC2 17 PHE A 268 THR A 272 ALA A 275 ILE A 309 SITE 2 AC2 17 MET A 312 LEU A 313 THR A 316 LEU A 345 SITE 3 AC2 17 PHE A 349 ILE A 353 HIS A 435 GLN A 438 SITE 4 AC2 17 LEU A 442 LEU A 449 LEU A 453 TRP A 457 SITE 5 AC2 17 BNS A1500 SITE 1 AC3 7 PHE B 271 LEU B 274 SER B 278 MET B 312 SITE 2 AC3 7 THR B 316 PHE B 329 44B B2501 SITE 1 AC4 16 PHE B 268 ILE B 309 MET B 312 LEU B 313 SITE 2 AC4 16 THR B 316 LEU B 345 PHE B 349 ILE B 353 SITE 3 AC4 16 HIS B 435 GLN B 438 VAL B 439 LEU B 442 SITE 4 AC4 16 LEU B 449 LEU B 453 TRP B 457 BNS B2500 SITE 1 AC5 6 PHE C 271 LEU C 274 ALA C 275 SER C 278 SITE 2 AC5 6 PHE C 329 44B C3501 SITE 1 AC6 16 PHE C 268 THR C 272 ALA C 275 MET C 312 SITE 2 AC6 16 LEU C 313 THR C 316 LEU C 345 PHE C 349 SITE 3 AC6 16 ILE C 353 HIS C 435 GLN C 438 LEU C 442 SITE 4 AC6 16 LEU C 449 LEU C 453 TRP C 457 BNS C3500 SITE 1 AC7 4 PHE D 271 SER D 278 MET D 312 44B D4501 SITE 1 AC8 15 THR D 272 ALA D 275 ILE D 309 MET D 312 SITE 2 AC8 15 LEU D 313 THR D 316 LEU D 345 PHE D 349 SITE 3 AC8 15 ILE D 353 HIS D 435 GLN D 438 LEU D 442 SITE 4 AC8 15 LEU D 449 TRP D 457 BNS D4500 CRYST1 58.866 103.606 176.378 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016988 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009652 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005670 0.00000